Researchers investigate how birth weight determines kidney function changes following prolonged physical activity in ...
21h
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
InflaRx intends to develop izicopan in ANCA-associated vasculitis (AAV), with a secondary goal of establishing rapid proof of concept in ...
Men’s Health spoke to Thomas Kruse and Jesper Lau, two chemists responsible for creating the drug that’s revolutionized how ...
It is the second licensing deal involving siRNA between GSK and a Chinese biotech in the last few months, coming after the UK ...
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
SCYNEXIS, Inc. (Nasdaq: SCYX) ('SCYNEXIS” or the 'Company”), a biotechnology company focused on developing innovative new therapies to address severe rare diseases including SCY-770 for Autosomal ...
The Hearty Soul on MSN
Key new driver of 11 cancers in under-50s identified - and it's not smoking or poor diet
Something has quietly shifted in oncology waiting rooms. For decades, a cancer diagnosis before age 50 was the exception – an ...
All Penny Stocks (English) on MSN
Biotech surges as big money backs high-stakes kidney disease push
The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory ...
For many people, the day does not truly start until drinking a cup of coffee in the morning. While this caffeinated drink ...
Portfolio Receipts growth of 10% to $925 million; Royalty Receipts growth of 13%Net cash provided by operating activities of $718 millionRaised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results